Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces its pioneering efforts to develop ...

Smith & Nephew has opened up to a possible break-up of the company amid activist pressure to consider a separation of its ...

Smith & Nephew (NYSE:SNN) quickly edged higher by ~1% after a r e port that it's considering a break-up amid activist ...

Berenberg raised the firm’s price target on Smith & Nephew to 1,100 GBp from 1,050 GBp and keeps a Hold rating on the shares.Discover the ...

Smith+Nephew announced today that it aims to develop technology in a new field of arthroscopic surgical innovation.

Despite ongoing pressures in China, revenue and trading profit at the FTSE 100 firm rose 5.3% and 8.2% respectively in 2024.

Smith+Nephew submitted its TESSA System for FDA 510 (k) clearance, according to a March 4 news release. TESSA, which stands for Tracking Enabled Spatial Surgery Assistant, is pending FDA clearance for ...

Smith & Nephew Plc Chief Executive Officer Deepak Nath said a transformation plan unveiled two years ago will clearly start ...

New York State Common Retirement Fund reduced its holdings in shares of Smith & Nephew plc (NYSE:SNN – Free Report) by 0.5% ...

The medical-technology company was boosted by its sports medicine segment and an improved trading margin.

The chief executive of medical device maker Smith & Nephew has rejected shareholder calls to break up the business, as the ...

Good morning, and welcome to the Smith & Nephew Q4 and full year 2024 Results Presentation. I’m Deepak Nath, I’m the Chief ...